Bausch Health Cos Current Ratio 2006-2019 | BHC

Current and historical current ratio for Bausch Health Cos (BHC) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bausch Health Cos current ratio for the three months ending March 31, 2019 was 1.09.
Bausch Health Cos Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $4.28B $3.94B 1.09
2018-12-31 $4.21B $3.84B 1.10
2018-09-30 $4.74B $4.16B 1.14
2018-06-30 $4.64B $4.07B 1.14
2018-03-31 $4.72B $3.99B 1.18
2017-12-31 $4.75B $4.27B 1.11
2017-09-30 $5.94B $4.73B 1.26
2017-06-30 $5.99B $4.47B 1.34
2017-03-31 $5.33B $4.25B 1.26
2016-12-31 $5.08B $3.61B 1.41
2016-09-30 $5.67B $3.90B 1.46
2016-06-30 $5.82B $4.23B 1.38
2016-03-31 $6.23B $4.60B 1.36
2015-12-31 $5.51B $5.31B 1.04
2015-09-30 $7.00B $4.65B 1.50
2015-06-30 $6.35B $4.29B 1.48
2015-03-31 $16.19B $3.10B 5.23
2014-12-31 $4.13B $2.71B 1.53
2014-09-30 $4.41B $3.14B 1.40
2014-06-30 $5.16B $2.50B 2.07
2014-03-31 $3.95B $2.56B 1.54
2013-12-31 $3.89B $2.51B 1.55
2013-09-30 $3.85B $2.85B 1.35
2013-06-30 $4.53B $1.76B 2.57
2013-03-31 $2.37B $1.65B 1.44
2012-12-31 $2.78B $1.82B 1.52
2012-09-30 $1.71B $1.16B 1.48
2012-06-30 $1.63B $1.05B 1.55
2012-03-31 $1.53B $0.96B 1.60
2011-12-31 $1.36B $0.92B 1.47
2011-09-30 $1.10B $0.86B 1.27
2011-06-30 $1.05B $0.76B 1.37
2011-03-31 $1.28B $0.66B 1.93
2010-12-31 $1.02B $0.69B 1.47
2010-09-30 $1.30B $0.85B 1.54
2010-06-30 $0.41B $0.23B 1.77
2010-03-31 $0.34B $0.21B 1.63
2009-12-31 $0.34B $0.25B 1.38
2009-09-30 $0.25B $0.22B 1.14
2009-06-30 $0.25B $0.22B 1.13
2009-03-31 $0.47B $0.23B 2.03
2008-12-31 $0.49B $0.27B 1.84
2008-09-30 $0.42B $0.19B 2.21
2008-06-30 $0.66B $0.35B 1.89
2008-03-31 $0.74B $0.39B 1.88
2007-12-31 $0.71B $0.37B 1.92
2007-09-30 $0.62B $0.23B 2.69
2007-06-30 $0.67B $0.28B 2.44
2007-03-31 $1.08B $0.74B 1.46
2006-12-31 $1.06B $0.41B 2.58
2006-09-30 $0.93B $0.27B 3.39
2006-06-30 $0.79B $0.26B 3.09
2006-03-31 $0.72B $0.26B 2.74
2005-12-31 $0.69B $0.27B 2.50
2005-09-30 $0.56B $0.21B 2.70
2005-06-30 $0.46B $0.22B 2.05
2005-03-31 $0.33B $0.19B 1.71
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $8.153B $8.380B
Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $53.845B 9.81
Mylan (MYL) United Kingdom $9.500B 4.15
Teva Pharmaceutical Industries (TEVA) Israel $8.338B 3.27
Dr Reddy's Laboratories (RDY) India $6.384B 23.88
ASPEN PHARMACR (APNHY) South Africa $3.351B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.674B 16.73
Amphastar Pharmaceuticals (AMPH) United States $0.946B 52.87
Voyager Therapeutics (VYGR) United States $0.911B 0.00
Homology Medicines (FIXX) United States $0.898B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.687B 1.02
Akorn (AKRX) United States $0.529B 0.00
CymaBay Therapeutics (CBAY) United States $0.449B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.449B 0.00
Assembly Biosciences (ASMB) United States $0.349B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.284B 0.00
Sol-Gel Technologies (SLGL) Israel $0.191B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.165B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.059B 0.00